At the end of the latest market close, Revolution Medicines Inc. (RVMD) was valued at $22.98. In that particular session, Stock kicked-off at the price of $22.81 while reaching the peak value of $22.83 and lowest value recorded on the day was $21.80. The stock current value is $22.24.Recently in News on March 7, 2023, Revolution Medicines Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares. Underwriters’ full exercise of option brings gross proceeds to $345.0 million. You can read further details here
Revolution Medicines Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $31.37 on 01/13/23, with the lowest value was $14.08 for the same time period, recorded on 05/12/22.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Sponsored
Revolution Medicines Inc. (RVMD) full year performance was 21.53%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Revolution Medicines Inc. shares are logging -29.10% during the 52-week period from high price, and 57.95% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $14.08 and $31.37.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 563534 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Revolution Medicines Inc. (RVMD) recorded performance in the market was -6.63%, having the revenues showcasing -4.55% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 2.47B, as it employees total of 246 workers.
Analysts verdict on Revolution Medicines Inc. (RVMD)
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 23.68, with a change in the price was noted +4.56. In a similar fashion, Revolution Medicines Inc. posted a movement of +25.79% for the period of last 100 days, recording 1,119,221 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for RVMD is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Revolution Medicines Inc. (RVMD): Technical Analysis
Raw Stochastic average of Revolution Medicines Inc. in the period of last 50 days is set at 21.77%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 30.09%. In the last 20 days, the company’s Stochastic %K was 37.76% and its Stochastic %D was recorded 35.73%.
Let’s take a glance in the erstwhile performances of Revolution Medicines Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -6.63%. Additionally, trading for the stock in the period of the last six months notably improved by 12.10%, alongside a boost of 21.53% for the period of the last 12 months. The shares increased approximately by 2.49% in the 7-day charts and went up by -12.75% in the period of the last 30 days. Common stock shares were lifted by -4.55% during last recorded quarter.
